• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Haemonetics

Haemonetics to lay off 170 in GlobalMed integration

April 6, 2010 By MassDevice staff Leave a Comment

HAE logo

Haemonetics Corp. (NYSE:HAE) plans to lay off about 170 workers and close facilities in Phoenix and Chicago as it integrates its new, $61 million acquisition, GlobalMed Technologies (OTC:GLOB).

Filed Under: Blood Management, Business/Financial News, News Well Tagged With: GlobalMed Technologies, Haemonetics

Haemonetics closes GlobalMed tender offer

April 1, 2010 By MassDevice staff Leave a Comment

HAE logo

Haemonetics Corp. (NYSE HAE) owns about 90 percent of GlobalMed Technologies Inc. this morning, after its extended tender offer for the California-based software provider expired at midnight March 31.

Filed Under: Blood Management, Business/Financial News, Mergers & Acquisitions, News Well Tagged With: GlobalMed Technologies, Haemonetics

Nutter squirrels away $2.7 million from recent stock sales

March 25, 2010 By MassDevice staff Leave a Comment

Nearly a year after stepping down as CEO at Haemonetics Corp. (NYSE:HAE), Brad Nutter cashed in another bloc of his holding’s in the blood management firm.

Nutter exercised just more than 173,000 options to purchase Haemonetics stock granted in July 2006 under a long-term incentive program for top executives. The options were priced at $41.15 a share and he promptly the sold the stock for $57 each — a $15.85-per-share profit resulting in net proceeds of nearly $2.75 million.

Filed Under: Business/Financial News, News Well Tagged With: Haemonetics

Haemonetics licenses Alba Bioscience blood typing reagents

March 19, 2010 By MassDevice staff Leave a Comment

HAE logo

Haemonetics Corp. (NYSE:HAE) inked a deal with Quotient Biodiagnostics Group subsidiary Alba Bioscience Ltd. that gives it exclusive access to Alba’s portfolio of blood-typing reagents.

The Braintree, Mass.-based blood management products maker will use the reagents for the Arryx laser blood typing platform, which CEO Brian Concannon calls the entry point into a billion-dollar market.

Filed Under: Blood Management, Business/Financial News, Dental, News Well Tagged With: Alba Bioscience, Haemonetics, Quotient Biodiagnostics Group

Haemonetics extends GlobalMed offer

March 18, 2010 By MassDevice staff Leave a Comment

HAE logo

Haemonetics Corp. (NYSE:HAE) extended its offer for GlobalMed Technologies Inc. to give the California-based software provider time to settle a shareholders lawsuit filed to block the acquisition.

Braintree, Mass.-based Haemonetics issued a $1.22-per-share offer, worth about $60 million and set to expire tonight at midnight, for GlobalMed Feb. 1.

Filed Under: Blood Management, Business/Financial News, News Well Tagged With: GlobalMed Technologies, Haemonetics

Haemonetics wins further 510(k) clearance for blood collection

February 22, 2010 By MassDevice staff Leave a Comment

The Food & Drug Administration expanded a 510(k) clearance for a Haemonetics Corp. (NYSE:HAE) device used to collect blood.

The Braintree, Mass.-based firm said the FDA expanded its clearance to use its Cymbal automated blood collection system for female blood donors who weigh at least 150 pounds and are 63 inches in height.

Filed Under: Blood Management, Business/Financial News, News Well Tagged With: Haemonetics

Haemonetics drops $60 million on GlobalMed, posts Q3 gains

February 1, 2010 By MassDevice staff Leave a Comment

Haemonetics Corp. (NYSE:HAE) is expanding its reach into hospital and blood center management, announcing a definitive agreement to pay $60 million for a California-based healthcare software company.

Company executives said the deal — the company’s fourth in less than a year — for GlobalMed Technologies Inc. should significantly expand Haemonetics’ offerings for blood-collection centers with little overlap of its existing business. The acquisition also should broaden Haemonetics’ presence in Europe and Asia, they said.

Filed Under: Blood Management, Business/Financial News, News Well, Software / IT Tagged With: GlobalMed Technologies, Haemonetics

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 9
  • Go to page 10
  • Go to page 11

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS